285 related articles for article (PubMed ID: 11707392)
21. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.
Hülsken J; Birchmeier W; Behrens J
J Cell Biol; 1994 Dec; 127(6 Pt 2):2061-9. PubMed ID: 7806582
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
23. The adenomatous polyposis coli (APC) tumor suppressor.
Polakis P
Biochim Biophys Acta; 1997 Jun; 1332(3):F127-47. PubMed ID: 9196022
[TBL] [Abstract][Full Text] [Related]
24. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion.
Barth AI; Pollack AL; Altschuler Y; Mostov KE; Nelson WJ
J Cell Biol; 1997 Feb; 136(3):693-706. PubMed ID: 9024698
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
26. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
27. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Kohler EM; Brauburger K; Behrens J; Schneikert J
Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
[TBL] [Abstract][Full Text] [Related]
28. Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein.
Munemitsu S; Albert I; Rubinfeld B; Polakis P
Mol Cell Biol; 1996 Aug; 16(8):4088-94. PubMed ID: 8754807
[TBL] [Abstract][Full Text] [Related]
29. Association of the APC gene product with beta-catenin.
Rubinfeld B; Souza B; Albert I; Müller O; Chamberlain SH; Masiarz FR; Munemitsu S; Polakis P
Science; 1993 Dec; 262(5140):1731-4. PubMed ID: 8259518
[TBL] [Abstract][Full Text] [Related]
30. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
Korinek V; Barker N; Morin PJ; van Wichen D; de Weger R; Kinzler KW; Vogelstein B; Clevers H
Science; 1997 Mar; 275(5307):1784-7. PubMed ID: 9065401
[TBL] [Abstract][Full Text] [Related]
31. Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells.
Baulida J; Batlle E; García De Herreros A
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):565-70. PubMed ID: 10567241
[TBL] [Abstract][Full Text] [Related]
32. Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions.
Huang Z; Zhang M; Burton SD; Katsakhyan LN; Ji H
ACS Chem Biol; 2014 Jan; 9(1):193-201. PubMed ID: 24191653
[TBL] [Abstract][Full Text] [Related]
33. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
34. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene.
Rubinfeld B; Albert I; Porfiri E; Munemitsu S; Polakis P
Cancer Res; 1997 Oct; 57(20):4624-30. PubMed ID: 9377578
[TBL] [Abstract][Full Text] [Related]
35. The fourth armadillo repeat of plakoglobin (gamma-catenin) is required for its high affinity binding to the cytoplasmic domains of E-cadherin and desmosomal cadherin Dsg2, and the tumor suppressor APC protein.
Ozawa M; Terada H; Pedraza C
J Biochem; 1995 Nov; 118(5):1077-82. PubMed ID: 8749329
[TBL] [Abstract][Full Text] [Related]
36. ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules.
Daniels DL; Weis WI
Mol Cell; 2002 Sep; 10(3):573-84. PubMed ID: 12408825
[TBL] [Abstract][Full Text] [Related]
37. Tcf4 can specifically recognize beta-catenin using alternative conformations.
Graham TA; Ferkey DM; Mao F; Kimelman D; Xu W
Nat Struct Biol; 2001 Dec; 8(12):1048-52. PubMed ID: 11713475
[TBL] [Abstract][Full Text] [Related]
38. The ins and outs of APC and beta-catenin nuclear transport.
Henderson BR; Fagotto F
EMBO Rep; 2002 Sep; 3(9):834-9. PubMed ID: 12223464
[TBL] [Abstract][Full Text] [Related]
39. beta-catenin: molecular plasticity and drug design.
Daniels DL; Eklof Spink K; Weis WI
Trends Biochem Sci; 2001 Nov; 26(11):672-8. PubMed ID: 11701326
[TBL] [Abstract][Full Text] [Related]
40. The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin.
Liu J; Xing Y; Hinds TR; Zheng J; Xu W
J Mol Biol; 2006 Jun; 360(1):133-44. PubMed ID: 16753179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
